期刊文献+

鲍曼不动杆菌的临床分布特征及耐药性分析

The Analysis on Resistance and Clinical Distribution Characteristics of Acinetobacter Baumannii
下载PDF
导出
摘要 目的:分析医院感染常见非发酵菌鲍曼不动杆菌的分布特征及耐药情况。方法:常规方法进行细菌培养鉴定,K-B法检测鲍曼不动杆菌对10种抗生素的药敏结果。结果:189株鲍曼不动杆菌分布各异,对10种抗生素均存在耐药,耐药率为9.2%~79.3%。结论:鲍曼不动杆菌已成为医院感染的重要致病菌,对多种抗生素存在高耐药率,而且耐药率在逐年上升,指导临床合理用药,药敏检测工作具有非常重要的意义。 Objective To analyze the characteristics of clinical distribution and the resistance of common non-fermentative Acinetobacter baumannii in hospital infection .Metheds To identify the bacteria culture in conventional method, K-B was used to detect these types of Acinetobacter baumannii to 10 antimicrobial agents in sensitive results. Results 189 cases' Acinetobacter baumannii were different distribution, they were detected to 10 antimicrobial agents in sensitive results, the resistance was 9.2%-79.3%. Conclusions Acinetobacter baumannii has become a major hospital infection pathogens, there was a high rate for a variety of antibiotic resistance, and the resistance rate is rising year on year. It may be of important value for instructing to apply drugs reasonably, and examining susceptibility testing work.
出处 《实用医技杂志》 2007年第22期2963-2964,共2页 Journal of Practical Medical Techniques
关键词 鲍曼不动杆菌 抗生素 耐药性 Acinetobacter baumannii Antibacterial drugs Resistance
  • 相关文献

参考文献3

二级参考文献39

  • 1王辉,刘颖梅,陈民钧,孙宏莉,谢秀丽,徐英春.鲍曼不动杆菌对碳青霉烯类耐药机制的研究[J].中国医学科学院学报,2003,25(5):567-572. 被引量:44
  • 2周月清,陆开来,糜祖煌.鲍曼不动杆菌TEM基因及氨基糖苷类修饰酶基因初步研究[J].中华检验医学杂志,2005,28(2):200-202. 被引量:64
  • 3Sengupta S, Kumar P, Ciraj AM, et al. Acinetobacter baumannii-An emerging nosocomial pathogen in the bums unit Manipal, india. Bums,2001, 27(2):140-144.
  • 4Vahaboglu H, Ozturk R, Aygun G , et al. Widespread detection of PER-1-type extended-spectrum b-lactarnases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide muhicenter stndy. Antimicrob Agents Chemother 1997 ; 41 (10) : 2265-2269.
  • 5Poirel L, Menuteau O, Agoli N, et al. Outbreak of extended-spectrum b-lactmase VEB-1 producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003 ; 41 ( 8 ) : 3542-3547.
  • 6Danes C, Navia MM, Ruiz J, etal. Distribution of beta-lactamases in Acinetobacter baumannii clinical isolates and the effect of Svn 2190 ( Am-pC inhibitor) on the MICs of different beta-lactam antibiotics. J Antimicrob Chemother., 2002 Aug; 50(2) : 261-264.
  • 7Limansky AS, Mussi Ma, Viale AM, et al. Loss of 29kD outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance. J Clin Microb. 2002, 40(12) : 4776-4778.
  • 8Costa SF. Outer membrane proteins pattern and detection of β-Lactamases in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil. Int J Antimicrob Agents, 2000, 13 (3) : 175.
  • 9Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC, et al. Relationship between beta-lactamases production, outer membrane protein and penicillin-binding protein profile on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy, 2003,51 ( 3 ) : 565-574.
  • 10Donald HM, Scaife W, Amyes SG, et al. Sequence analysis of ARI-1, a novel OXAβ-lactamase, responsible for imipenem resistance in Acinetobacter baumanii. Antimicrob Agents Chemother, 2000,44 ( 1 ) : 196-199.

共引文献307

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部